Zhang Li, Cao Siyu, Marsh Nicole, Ray-Barruel Gillian, Flynn Julie, Larsen Emily, Rickard Claire M
AVATAR Group, Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
Centre for Clinical Nursing, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia.
J Infect Prev. 2016 Sep;17(5):207-213. doi: 10.1177/1757177416655472. Epub 2016 Jul 6.
Peripheral vascular catheters (PVC) are the most frequently used invasive medical devices in hospitals, with 330 million sold each year in the USA alone. One in three UK inpatients at any one time has at least one PVC according to the Scottish National Prevalence survey.
A narrative review of studies describing the infection risks associated with PVCs.
It is estimated that 30-80% of hospitalised patients receive at least one PVC during their hospital stay. Despite their prevalence, PVCs are not benign devices, and the high number of PVCs inserted annually has resulted in serious catheter-related bloodstream infections and significant morbidity, prolonged hospital stay and increased healthcare system costs. To date, PVC infections have been under-evaluated. Most studies focus on central venous catheter rather than PVC-associated bloodstream infections. Risks associated with PVC infection must be addressed to reduce patient morbidity and associated costs of prolonged hospital admission and treatment.
This article discusses the sources and routes of PVC-associated infection and outlines known effective prevention and intervention strategies.
外周血管导管(PVC)是医院中使用最频繁的侵入性医疗设备,仅在美国每年就售出3.3亿根。根据苏格兰全国患病率调查,英国任何时候三分之一的住院患者至少有一根PVC。
对描述与PVC相关感染风险的研究进行叙述性综述。
据估计,30%-80%的住院患者在住院期间至少接受一根PVC。尽管PVC很普遍,但它们并非无害设备,每年大量插入PVC导致了严重的导管相关血流感染和显著的发病率、延长住院时间以及增加医疗系统成本。迄今为止,PVC感染评估不足。大多数研究集中于中心静脉导管而非与PVC相关的血流感染。必须解决与PVC感染相关的风险,以降低患者发病率以及延长住院和治疗的相关成本。
本文讨论了与PVC相关感染的来源和途径,并概述了已知的有效预防和干预策略。